Whalerock Point Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,875
Closed -$298K 127
2020
Q2
$298K Sell
3,875
-1,300
-25% -$99.6K 0.18% 90
2020
Q1
$387K Sell
5,175
-659
-11% -$45.5K 0.28% 73
2019
Q4
$379K Sell
5,834
-1,361
-19% -$88.6K 0.2% 97
2019
Q3
$456K Sell
7,195
-44
-0.6% -$2.88K 0.25% 82
2019
Q2
$489K Hold
7,239
0.28% 77
2019
Q1
$471K Buy
7,239
+570
+9% +$37.9K 0.31% 72
2018
Q4
$417K Sell
6,669
-750
-10% -$52.4K 0.39% 62
2018
Q3
$573K Sell
7,419
-975
-12% -$73.6K 0.42% 65
2018
Q2
$595K Sell
8,394
-9,150
-52% -$646K 0.48% 58
2018
Q1
$1.32M Sell
17,544
-6,590
-27% -$524K 0.42% 48
2017
Q4
$1.73M Sell
24,134
-6,625
-22% -$503K 0.55% 37
2017
Q3
$2.49M Sell
30,759
-581
-2% -$44.4K 0.88% 21
2017
Q2
$2.22M Sell
31,340
-3,475
-10% -$231K 0.81% 26
2017
Q1
$2.36M Sell
34,815
-1,920
-5% -$135K 0.88% 24
2016
Q4
$2.63M Sell
36,735
-19,470
-35% -$1.45M 1.04% 20
2016
Q3
$4.45M Buy
+56,205
New +$4.57M 1.84% 9
2016
Q1
$4.96M Buy
54,015
+3,610
+7% +$326K 2.14% 4
2015
Q4
$5.1M Sell
50,405
-4,572
-8% -$476K 2.22% 5
2015
Q3
$5.4M Buy
54,977
+4,565
+9% +$507K 2.33% 4
2015
Q2
$5.9M Buy
50,412
+4,170
+9% +$456K 2.44% 4
2015
Q1
$4.54M Sell
46,242
-1,355
-3% -$138K 1.85% 7
2014
Q4
$4.49M Buy
47,597
+1,727
+4% +$179K 1.89% 6
2014
Q3
$4.88M Buy
45,870
+15,865
+53% +$1.55M 2.2% 5
2014
Q2
$2.49M Buy
30,005
+5,939
+25% +$462K 1.18% 14
2014
Q1
$1.71M Buy
24,066
+10,945
+83% +$858K 0.87% 25
2013
Q4
$985K Buy
+13,121
New +$914K 0.52% 38

Other funds holding GILD

Whalerock Point Partners's GILD Position: Q3 2020 in Review

Whalerock Point Partners sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,875 shares — an estimated $298K sold.

Whalerock Point Partners first reported a position in GILD in Q4 2013 and held it in 26 quarters. The position peaked at $5.9M in Q2 2015. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Whalerock Point Partners reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Whalerock Point Partners sold 3,875 Gilead Sciences shares in Q3 2020, an estimated $298K.
  • Whalerock Point Partners first reported a position in Gilead Sciences in Q4 2013 and held it in 26 quarters.
  • Whalerock Point Partners's Gilead Sciences position peaked at $5.9M in Q2 2015.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Whalerock Point Partners's 13F filing for Q3 2020, filed 13 Nov 2020.